Lack of a Significant Drug Interaction between Raltegravir and Tenofovir

Raltegravir is a novel human immunodeficiency virus type 1 (HIV-1) integrase inhibitor with potent in vitro activity (95% inhibitory concentration of 31 nM in 50% human serum). This article reports the results of an open-label, sequential, three-period study of healthy subjects. Period 1 involved ra...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Wenning, Larissa A., Friedman, Evan J., Kost, James T., Breidinger, Sheila A., Stek, Jon E., Lasseter, Kenneth C., Gottesdiener, Keith M., Chen, Joshua, Teppler, Hedy, Wagner, John A., Stone, Julie A., Iwamoto, Marian
Format: Artigo
Sprog:Inglês
Udgivet: American Society for Microbiology (ASM) 2008
Fag:
Antiviral Agents
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2533504/
https://ncbi.nlm.nih.gov/pubmed/18625763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00005-08
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker